James A Geraghty is Director of PIERIS PHARMACEUTICALS, INC.. Currently has a direct ownership of 0 shares of PIRS, which is worth approximately $0. The most recent transaction as insider was on Dec 12, 2024, when has been sold 1 shares (Series F Preferred Stock, par value $0.001 per share) at a price of $0.01 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
n/a 12M change
Total Value Held $0

JAMES A GERAGHTY Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 12 2024
SELL
Sale (or disposition) back to the issuer
$0 $0.01 p/Share
1 Reduced 100.0%
0 Series F Preferred Sto...
Aug 07 2024
BUY
Open market or private purchase
$1 $1.0 p/Share
1 Added 50.0%
1 Series F Preferred Sto...

Also insider at

VYGR
Voyager Therapeutics, Inc. Healthcare
FULC
Fulcrum Therapeutics, Inc. Healthcare
ORTX
Orchard Therapeutics plc Healthcare
IDRA
IDERA PHARMACEUTICALS, INC. Healthcare
JAG

James A Geraghty

Director
Exton, PA

Track Institutional and Insider Activities on PIRS

Follow PIERIS PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PIRS shares.

Notify only if

Insider Trading

Get notified when an Pieris Pharmaceuticals, Inc. insider buys or sells PIRS shares.

Notify only if

News

Receive news related to PIERIS PHARMACEUTICALS, INC.

Track Activities on PIRS